A case report on efficacy of Abound™ for anti-EGFR antibody-associated skin disorder in metastatic colon cancer

BACKGROUND: Panitumumab is a full human epidermal growth factor receptor (EGFR) monoclonal antibody, an agent for metastatic colorectal cancer therapy. One of the most general adverse events of anti-EGFR monoclonal antibody therapy is skin disorder. At the present time, although prophylaxis of skin...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuhashi, Nobuhisa, Takahashi, Takao, Nonaka, Kenichi, Ichikawa, Kengo, Yawata, Kazunori, Tanahashi, Toshiyuki, Imai, Hisashi, Sasaki, Yoshiyuki, Tanaka, Yoshihiro, Okumura, Naoki, Yamaguchi, Kazuya, Osada, Shinji, Yoshida, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922949/
https://www.ncbi.nlm.nih.gov/pubmed/24517087
http://dx.doi.org/10.1186/1477-7819-12-35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922949/
https://www.ncbi.nlm.nih.gov/pubmed/24517087
http://dx.doi.org/10.1186/1477-7819-12-35

Ejemplares similares